GLPwatch

Exendin-4 analogs in insulinoma theranostics.

J Labelled Comp Radiopharm · 2019

Last updated 2026-05-28
JournalJ Labelled Comp Radiopharm, 2019
Citations54
Relative citation ratio3.15
NIH percentile85
Molecules

Abstract

Insulinomas, neuroendocrine tumors arising from pancreatic beta cells, often show overexpression of the glucagon-like peptide-1 receptor. Therefore, imaging with glucagon-like peptide analog exendin-4 can be used for diagnosis and preoperative localization. This review presents an overview of the development and clinical implementation of exendin-based tracers for nuclear imaging, and the potential use of exendin-4 based tracers for optical imaging and therapeutic applications such as peptide receptor radionuclide therapy or targeted photodynamic therapy.

Verbatim abstract via PubMed 31070270 ↗